Volpara Health Technologies Ltd
ASX:VHT
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| NZ |
|
Volpara Health Technologies Ltd
ASX:VHT
|
291.3m AUD |
Loading...
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
Loading...
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
28.8B USD |
Loading...
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12.1B AUD |
Loading...
|
|
| JP |
|
M3 Inc
TSE:2413
|
1T JPY |
Loading...
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.8B USD |
Loading...
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD |
Loading...
|
|
| SE |
|
Sectra AB
STO:SECT B
|
34.6B SEK |
Loading...
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
23.3B CNY |
Loading...
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
Loading...
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
240.5B INR |
Loading...
|
Market Distribution
| Min | -127.6% |
| 30th Percentile | 37.1% |
| Median | 51% |
| 70th Percentile | 64.7% |
| Max | 107.2% |
Other Profitability Ratios
Volpara Health Technologies Ltd
Glance View
Volpara Health Technologies Ltd. engages in selling the VolparaEnterprise software, which is a cloud-based breast imaging analytics product. The firm is engaged in developing digital health solutions to enable personalized breast cancer screening based on objective measurements of breast density, compression, and radiation dose. Its geographic segments include North America, Europe, the Middle East and Africa (EMEA), Asia-Pacific (APAC), and Corporate. The firm's offerings include VolparaEnterprise, which enables breast imaging providers to perform control checks; VolparaDensity, which provides objective assessment of a woman's breast density; VolparaRisk is a software that features a patient questionnaire; VolparaLive provides technologists with real-time decision support at the point of care to assess image quality, and Aspen Brest, which is a workflow software that optimizes operations and administration for breast cancer screening programs.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Volpara Health Technologies Ltd is 92.3%, which is below its 3-year median of 92.4%.
Over the last 3 years, Volpara Health Technologies Ltd’s Gross Margin has increased from 88.2% to 92.3%. During this period, it reached a low of 88.2% on Sep 30, 2020 and a high of 92.5% on Mar 31, 2023.
